Heicappell R - Search Results

1

Expression of CD44V2 in transitional cell carcinoma of the urinary bladder and in urine.

Müller M, Heicappell R, Habermann F, Kaufmann M, Steiner U, Miller K. Müller M, et al. Among authors: heicappell r. Urol Res. 1997;25(3):187-92. doi: 10.1007/BF00941981. Urol Res. 1997. PMID: 9228671

2

Photodynamic effects of sulfonated aluminum chlorophthalocyanine in human urinary bladder carcinoma cells in vitro.

Müller M, Reich E, Steiner U, Heicappell R, Miller K. Müller M, et al. Among authors: heicappell r. Eur Urol. 1997;32(3):339-43. Eur Urol. 1997. PMID: 9358224

3

Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.

Heine B, Hummel M, Müller M, Heicappell R, Miller K, Stein H. Heine B, et al. Among authors: heicappell r. J Pathol. 1998 Jan;184(1):71-6. doi: 10.1002/(SICI)1096-9896(199801)184:1<71::AID-PATH988>3.0.CO;2-#. J Pathol. 1998. PMID: 9582530

4

Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.

Müller M, Krause H, Heicappell R, Tischendorf J, Shay JW, Miller K. Müller M, et al. Among authors: heicappell r. Clin Cancer Res. 1998 Aug;4(8):1949-54. Clin Cancer Res. 1998. PMID: 9717824

5

Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder.

Heicappell R, Wettig IC, Schostak M, Müller M, Steiner U, Sauter T, Miller K. Heicappell R, et al. Eur Urol. 1999 Jan;35(1):81-7. doi: 10.1159/000019822. Eur Urol. 1999. PMID: 9933798

6

Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.

Heicappell R, Schostak M, Müller M, Miller K. Heicappell R, et al. Scand J Clin Lab Invest. 2000 Jul;60(4):275-82. doi: 10.1080/003655100750046431. Scand J Clin Lab Invest. 2000. PMID: 10943597

7

Qualitative determination of urinary human complement factor H-related protein (hcfHrp) in patients with bladder cancer, healthy controls, and patients with benign urologic disease.

Heicappell R, Müller M, Fimmers R, Miller K. Heicappell R, et al. Urol Int. 2000;65(4):181-4. doi: 10.1159/000064872. Urol Int. 2000. PMID: 11112865 Clinical Trial.

8

Concomitment spread of a renal cell carcinoma beyond the kidney and a transitional cell carcinoma beyond the bladder.

Straub B, Müller M, Schrader M, Goessl C, Heicappell R, Miller K. Straub B, et al. Among authors: heicappell r. Int Urol Nephrol. 2000;32(2):249-50. doi: 10.1023/a:1007122832632. Int Urol Nephrol. 2000. PMID: 11229641 Review.

9

Side effects of chemotherapy for advanced urothelial carcinoma with etoposide and ifosfamide.

Müller M, Heicappell R, Steiner U, Goessl C, Miller K. Müller M, et al. Among authors: heicappell r. Urol Int. 1997;59(4):248-51. doi: 10.1159/000283073. Urol Int. 1997. PMID: 9444744

10

Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.

Goessl C, Heicappell R, Münker R, Anker P, Stroun M, Krause H, Müller M, Miller K. Goessl C, et al. Among authors: heicappell r. Cancer Res. 1998 Oct 15;58(20):4728-32. Cancer Res. 1998. PMID: 9788629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters